Cargando…
Paradox: Curcumin, a Natural Antioxidant, Suppresses Osteosarcoma Cells via Excessive Reactive Oxygen Species
Osteosarcoma (OS) is an aggressive tumor with a rare incidence. Extended surgical resections are the prevalent treatment for OS, which may cause critical-size bone defects. These bone defects lead to dysfunction, weakening the post-surgical quality of patients’ life. Hence, an ideal therapeutic agen...
Autores principales: | Xu, Chunfeng, Wang, Mingjie, Zandieh Doulabi, Behrouz, Sun, Yuanyuan, Liu, Yuelian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418684/ https://www.ncbi.nlm.nih.gov/pubmed/37569346 http://dx.doi.org/10.3390/ijms241511975 |
Ejemplares similares
-
To B (Bone Morphogenic Protein-2) or Not to B (Bone Morphogenic Protein-2): Mesenchymal Stem Cells May Explain the Protein’s Role in Osteosarcomagenesis
por: Xu, Chunfeng, et al.
Publicado: (2021) -
Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
por: Xu, Chunfeng, et al.
Publicado: (2021) -
Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance
por: Haghiralsadat, Fateme, et al.
Publicado: (2018) -
Osteosarcoma cells/cell lines are not appropriate for studies on bone regeneration in vitro
por: Xu, Chunfeng, et al.
Publicado: (2023) -
A Novel Approach on Drug Delivery:
Investigation of A New Nano-Formulation of Liposomal
Doxorubicin and Biological Evaluation of Entrapped
Doxorubicin on Various Osteosarcoma Cell Lines
por: Haghiralsadat, Fateme, et al.
Publicado: (2017)